Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/FRAZIER-LIFESCIENCES-ACQU-147300154/news/Newamsterdam-Pharma-Company-N-V-Completes-Enrollment-in-Pivotal-Phase-3-Broadway-Clinical-Trial-Eva-44417655/?utm_source=whatsapp&utm_medium=social&utm_campaign=share